Carol Dan Browning Appointed Chair of Pharmaceuticals & Medical Devices Litigation Group
LOUISVILLE, Ky.—Stites & Harbison, PLLC recently appointed Stites & Harbison, PLLC attorney Carol Dan Browning as Chair of the firm’s Pharmaceuticals & Medical Devices Litigation Group.
“We are incredibly happy to have Carol lead the Pharmaceuticals & Medical Devices Litigation Group,” stated Marjorie A. Farris, Chair of Stites & Harbison. “She is one of the top attorneys across the Midwest and Southeast regions of the country when it comes to product liability litigation. Her exemplary legal skills combined with her leadership experience at Stites will serve the firm and our clients well.”
Browning is a Member (Partner) based in Stites & Harbison’s Louisville, Ky., office. She is an accomplished trial attorney who has tried more than 35 cases to jury verdict in multiple jurisdictions. She is a Fellow of the American College of Trial Lawyers, North America’s preeminent organization of trial lawyers. Browning’s practice includes drug and medical device litigation, products liability and medical malpractice defense. She serves as national or state counsel for multiple drug, medical device and product manufacturers and is involved in multi-district litigation pending in various federal district courts and in coordinated litigation pending in state courts throughout Kentucky.
Browning stays active in a variety of professional and community organizations. She is a member of the Defense Research Institute, the International Association of Defense Counsel and the Product Liability Advisory Council. She also previously served on the Louisville Ballet’s Board of Directors. Within the firm, she is a former Chair of the Torts & Insurance Practice Service Group and a former member of the Management Committee.
Contact
Before sending, please note:
Information on www.stites.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.
Related Capabilities